These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 3919042

  • 1. Transient hypogonadotropic hypogonadism caused by critical illness.
    Woolf PD, Hamill RW, McDonald JV, Lee LA, Kelly M.
    J Clin Endocrinol Metab; 1985 Mar; 60(3):444-50. PubMed ID: 3919042
    [Abstract] [Full Text] [Related]

  • 2. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM, Gow SM, Wu FC.
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [Abstract] [Full Text] [Related]

  • 3. A study of the endocrine manifestations of hepatic cirrhosis.
    Baker HW, Burger HG, de Kretser DM, Dulmanis A, Hudson B, O'Connor S, Paulsen CA, Purcell N, Rennie GC, Seah CS, Taft HP, Wang C.
    Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039
    [Abstract] [Full Text] [Related]

  • 4. Both hyper- and hypogonadotropic hypogonadism occur transiently in acute illness: bio- and immunoactive gonadotropins.
    Spratt DI, Bigos ST, Beitins I, Cox P, Longcope C, Orav J.
    J Clin Endocrinol Metab; 1992 Dec; 75(6):1562-70. PubMed ID: 1464665
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
    van den Berghe G, Weekers F, Baxter RC, Wouters P, Iranmanesh A, Bouillon R, Veldhuis JD.
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192
    [Abstract] [Full Text] [Related]

  • 7. Fasting suppresses pulsatile luteinizing hormone (LH) secretion and enhances orderliness of LH release in young but not older men.
    Bergendahl M, Aloi JA, Iranmanesh A, Mulligan TM, Veldhuis JD.
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1967-75. PubMed ID: 9626127
    [Abstract] [Full Text] [Related]

  • 8. Hypogonadotropic hypogonadism: hormonal responses to low dose pulsatile administration of gonadotropin-releasing hormone.
    Valk TW, Corley KP, Kelch RP, Marshall JC.
    J Clin Endocrinol Metab; 1980 Oct; 51(4):730-8. PubMed ID: 6774991
    [Abstract] [Full Text] [Related]

  • 9. Hypogonadotropic hypogonadism in severe beta-thalassemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy.
    Wang C, Tso SC, Todd D.
    J Clin Endocrinol Metab; 1989 Mar; 68(3):511-6. PubMed ID: 2493034
    [Abstract] [Full Text] [Related]

  • 10. Differential control of luteinizing hormone and follicle-stimulating hormone secretion by luteinizing hormone-releasing hormone pulse frequency in man.
    Gross KM, Matsumoto AM, Bremner WJ.
    J Clin Endocrinol Metab; 1987 Apr; 64(4):675-80. PubMed ID: 3102545
    [Abstract] [Full Text] [Related]

  • 11. Multiple forms of hypogonadism of central, peripheral or combined origin in males with Prader-Willi syndrome.
    Radicioni AF, Di Giorgio G, Grugni G, Cuttini M, Losacco V, Anzuini A, Spera S, Marzano C, Lenzi A, Cappa M, Crinò A.
    Clin Endocrinol (Oxf); 2012 Jan; 76(1):72-7. PubMed ID: 21718342
    [Abstract] [Full Text] [Related]

  • 12. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
    Pavlou SN, Wakefield G, Schlechter NL, Lindner J, Souza KH, Kamilaris TC, Konidaris S, Rivier JE, Vale WW, Toglia M.
    J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
    [Abstract] [Full Text] [Related]

  • 13. Partial reversal of the hypogonadotropic hypogonadism of obese men by administration of corticosuppressive doses of dexamethasone.
    Zumoff B, Strain GW, Miller LK, Rosner W, Levit CD, Miller EH, Rosenfeld RS.
    Int J Obes; 1988 Feb; 12(6):525-31. PubMed ID: 3148562
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of the hypothalamic-pituitary-gonadal axis in eugonadal men with type 2 diabetes mellitus.
    Costanzo PR, Suárez SM, Scaglia HE, Zylbersztein C, Litwak LE, Knoblovits P.
    Andrology; 2014 Jan; 2(1):117-24. PubMed ID: 24282162
    [Abstract] [Full Text] [Related]

  • 15. Evidence for decreased luteinizing hormone-releasing hormone pulse frequency in men with selective elevations of follicle-stimulating hormone.
    Gross KM, Matsumoto AM, Southworth MB, Bremner WJ.
    J Clin Endocrinol Metab; 1985 Jan; 60(1):197-202. PubMed ID: 3917266
    [Abstract] [Full Text] [Related]

  • 16. Correlation between integrated LH and FSH levels and the response to luteinizing hormone relasing factor (LRF).
    Mortimer RH, Fleischer N, Lev-Gur M, Freeman RG.
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1240-9. PubMed ID: 794076
    [Abstract] [Full Text] [Related]

  • 17. Stimulation of serum inhibin concentrations by gonadotropin-releasing hormone in men with idiopathic hypogonadotropic hypogonadism.
    Sheckter CB, McLachlan RI, Tenover JS, Matsumoto AM, Burger HG, de Kretser DM, Bremner WJ.
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1221-4. PubMed ID: 3142917
    [Abstract] [Full Text] [Related]

  • 18. Normal adults and subjects with hypogonadotropic hypogonadism respond differently to D-Ser(TBU)6-LH-RH-EA10.
    Smith R, Donald RA, Espiner EA, Stronach SG, Edwards IA.
    J Clin Endocrinol Metab; 1979 Jan; 48(1):167-70. PubMed ID: 106067
    [Abstract] [Full Text] [Related]

  • 19. Effect of massive weight loss on hypothalamic-pituitary-gonadal function in obese men.
    Strain GW, Zumoff B, Miller LK, Rosner W, Levit C, Kalin M, Hershcopf RJ, Rosenfeld RS.
    J Clin Endocrinol Metab; 1988 May; 66(5):1019-23. PubMed ID: 3129444
    [Abstract] [Full Text] [Related]

  • 20. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M, Campaniello E, Michelacci L, Pareschi A, Ferrari P, Bolelli G, Flamigni C.
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.